Reply to A. Levy et al
J Clin Oncol
.
2013 Jan 20;31(3):396.
doi: 10.1200/JCO.2012.46.4867.
Authors
Rajul K Jain
,
J Jack Lee
,
David Hong
,
Razelle Kurzrock
PMID:
23451354
DOI:
10.1200/JCO.2012.46.4867
No abstract available
Publication types
Letter
Comment
MeSH terms
Antineoplastic Agents / therapeutic use*
Clinical Trials, Phase I as Topic*
Humans
Molecular Targeted Therapy*
Neoplasms / mortality*
Neoplasms / pathology*
Tumor Burden / drug effects*
Substances
Antineoplastic Agents
Grants and funding
UL1 RR024148/RR/NCRR NIH HHS/United States